Prime Medicine
Prime Medicine

PRME - Prime Medicine • Dividends

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
9/10/2019
0,8
Quarterly
6/14/2019
0,2
Quarterly
12/18/2018
0,213
Quarterly
9/14/2018
0,233
Quarterly
6/21/2018
0,146
Quarterly
3/22/2018
0,006
Quarterly
12/21/2017
0,861
Quarterly
9/21/2017
0,066
Quarterly
6/22/2017
0,112
Quarterly
3/23/2017
0,03
Quarterly
12/21/2016
0,727
Quarterly
9/21/2016
0,165
Quarterly
6/22/2016
0,166
Quarterly
3/23/2016
0,024
Quarterly
12/23/2015
0,087
Quarterly

The latest dividend from PRME was $0.80 per share (ex-dividend 9/10/2019). The dividend yield over the last 12 months is 0%.